The rapid increase of a number of diseases like obesity, cardiovascular problems, and cancers in the U.S., are contributing to the rise in the number of surgeries of open as well as minimally invasive type. Ongoing research and development of new technologies and innovations in the medical devices market of the country are boosting demand for surgical staplers. The U.S. surgical staplers market is expected to grow at a high CAGR through the forecast period.
Investment in research and development of advanced surgical stapling systems are expected to boost the market. The U.S. is one of the largest patent filers for surgical staplers and its related devices, with companies like Dextera Surgical, and Ethicon continuously researching to develop superior surgical staplers.
From the demand side too, the surgical staplers market in the U.S. looks strong. United States is likely to be witnessing an increasing demand for branded, generic drugs and medical devices from 2016 onwards as the number of insured individuals continues to grow under ACA and Medicaid. Between September 2013 and February 2015, 16.9 million Americans were newly insured. Under such coverages, people are expected to opt for surgeries, which without insurances would be expensive. This is expected to raise the demand for surgical staplers in the region.
The U.S. surgical staplers market is segmented by product into manual and powered surgical staplers and by type into reusable and disposable surgical staplers. Powered surgical staplers dominated the market share in 2017, and the reusable surgical staplers segment is expected to grow at a higher CAGR in the forecast period (2018-2023).
The U.S. surgical staplers market is further segmented based on its applications - abdominal surgery, cardiac surgery, orthopaedic surgery, general surgery and other surgeries. In 2017, the general surgeries segment held the biggest share of the market.
Key Growth Factors
- The percentage of the total population of the U.S. aged 65 and above will rise from 15% in 2015 to 21% by 2030. The growing population of the elderly, coupled with their specific age-related diseases, are supposed to drive the surgical staplers market.
- The United States of America was the largest medical devices market in the world, having a market share of 40% of the medical devices market globally in 2015. The country receives one of the highest foreign direct investment in the medical devices industry. The investments are expected to boost the surgical staplers market in the country.
Threats and Key Players
- According to the U.S. Food and Drug Administration, the use of surgical staplers results in 8,000 to 9,000 reported complications every year in the United States, with many resulting in injuries or death due to failure or misfire of staples, and due to staples that do not form properly. This is a major challenge for the adoption of surgical staplers in the region.
- The stringent procedure for all medical devices to be approved by the U.S. Food and Drug Administration (FDA), to be made available in the U.S. market is a hindrance to the growth of the market. The process can take years for the companies to be a part of an FDA trial for their equipment.
- The key players in the U.S. surgical staplers market are Ethicon (Johnson & Johnson), Covidien (Medtronic), 3M, B.Braun, Dextera Surgical, Intuitive Surgical, etc.
- B. Braun
- Covidien (Medtronic)
- Dextera Surgical
- Ethicon (Johnson & Johnson)
- Grena Ltd.
- Intuitive Surgical
- Purple Surgical
- Smith & Nephew
For more information about this report visit https://www.researchandmarkets.com/research/kdtkvz/u_s_surgical?w=4